Published in Vet Immunol Immunopathol on October 08, 2002
Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release (2012) 0.92
Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides. BMC Neurosci (2008) 0.88
Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with beta2-adrenergic agonist. Exp Mol Med (2009) 0.82
Transcutaneous DNA immunization following waxing-based hair depilation. J Control Release (2011) 0.80
The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin. J Pharm Pharmacol (2011) 0.79
Induction of mucosal immunity through systemic immunization: Phantom or reality? Hum Vaccin Immunother (2016) 0.79
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proc Natl Acad Sci U S A (1996) 1.33
Structure of transfer RNAs: listing of 150 additional sequences. Prog Nucleic Acid Res Mol Biol (1983) 1.30
Partial sequence analysis of cloned dengue virus type 2 genome. Gene (1986) 1.21
Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol (1998) 1.14
Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology (1988) 1.11
Green fluorescent protein as a noninvasive stress probe in resting Escherichia coli cells. Appl Environ Microbiol (1999) 1.11
Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J Virol (2001) 1.10
Generation of infectious pancreatic necrosis virus from cloned cDNA. J Virol (1998) 1.03
A recombinant Eimeria protein inducing interferon-gamma production: comparison of different gene expression systems and immunization strategies for vaccination against coccidiosis. Avian Dis (2000) 1.03
Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis. Virology (2001) 1.02
Detection of a new Mycobacterium species in wild striped bass in the Chesapeake Bay. J Clin Microbiol (2001) 1.01
Butyrophilin is expressed in mammary epithelial cells from a single-sized messenger RNA as a type I membrane glycoprotein. J Biol Chem (1998) 0.97
Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon. J Virol (2000) 0.97
Recombinant Newcastle disease virus as a vaccine vector. Poult Sci (2003) 0.94
Molecular cloning of the pheromone biosynthesis-activating neuropeptide in Helicoverpa zea. Proc Natl Acad Sci U S A (1992) 0.92
Molecular characterization of Sp serotype strains of infectious pancreatic necrosis virus exhibiting differences in virulence. Dis Aquat Organ (2004) 0.91
Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Arch Virol (1992) 0.91
Complete genome sequence of Newcastle disease virus mesogenic vaccine strain R2B from India. J Virol (2012) 0.90
Use of in situ hybridization for the detection of foot-and-mouth disease virus in cell culture. J Vet Diagn Invest (1989) 0.90
DNA vaccination in the avian. Vet Immunol Immunopathol (2002) 0.88
Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation. Virus Res (1994) 0.86
In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment. Ann Biomed Eng (2013) 0.86
Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus. Virus Res (1989) 0.85
Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography. Biotechnol Bioeng (1999) 0.84
Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis. Cell Prolif (2011) 0.82
The role of queuine in the aminoacylation of mammalian aspartate transfer RNAs. Nucleic Acids Res (1983) 0.82
Changes in the Cytokine and Toll-Like Receptor Gene Expression Following Infection of Indigenous and Commercial Chickens With Infectious bursal disease virus. Indian J Virol (2011) 0.82
The structure of aspartate transfer RNA from rabbit liver. Biochem Biophys Res Commun (1982) 0.81
Interaction of hepatic microsomal epoxide hydrolase derived from a recombinant baculovirus expression system with an azarene oxide and an aziridine substrate analogue. Biochemistry (1993) 0.81
In ovo delivery of DNA to the avian embryo. Vaccine (2003) 0.81
Immune responses elicited in rainbow trout through the administration of infectious pancreatic necrosis virus-like particles. Dev Comp Immunol (2011) 0.81
Serological evidence for a 793/B related avian infectious bronchitis virus in India. Vet Rec (1999) 0.80
Development of a subunit vaccine for infectious pancreatic necrosis virus using a baculovirus insect/larvae system. Dev Biol (Basel) (2005) 0.79
Genetic analysis of aquabirnaviruses isolated from wild fish reveals occurrence of natural reassortment of infectious pancreatic necrosis virus. J Fish Dis (2009) 0.79
Insect larval expression process is optimized by generating fusions with green fluorescent protein. Biotechnol Bioeng (1999) 0.79
Reversed-phase boronate chromatography for the separation of O-methylribose nucleosides and aminoacyl-tRNAs. Anal Biochem (1980) 0.79
Evaluation of an immunochromatography strip assay for the detection of Salmonella sp. from poultry. J Vet Diagn Invest (2002) 0.78
Characterisation of Newcastle disease viruses isolated in India. Zentralbl Veterinarmed B (1992) 0.78
Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens. Acta Vet Hung (1999) 0.78
Efficient fluorescence-based imaging methods for quantitating infectivity and oncolytic efficacy of Newcastle disease virus. J Virol Methods (2009) 0.78
Pathogenicity and immunosuppressive properties of infectious bursal disease virus field isolates and commercial vaccines in India. Trop Anim Health Prod (1998) 0.77
Quantitative counter-immunoelectrophoresis for estimation of antibodies to infectious bursal disease virus. Vet Res Commun (1994) 0.77
Evaluation of a filter paper blood sampling technique for quantitative assessment of antibodies to infectious bursal disease virus. Trop Anim Health Prod (2000) 0.77
Cell mediated immunity to Plasmodium vivax infection: in vitro inhibition of parasite growth by monocyte derived macrophages. J Assoc Physicians India (1999) 0.77
Effect of a variant infectious bursal disease virus (E/Del) on Salmonella typhimurium infection in commercial broiler chickens. Avian Dis (2004) 0.76
The detection and differentiation of foot-and-mouth disease viruses using solid-phase nucleic acid hybridization. J Virol Methods (1990) 0.76
Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins. Avian Dis (1995) 0.76
Monitoring foreign protein expression under baculovirus p10 and polh promoters in insect larvae. Biotechniques (2002) 0.75
Rocket immunoelectrophoresis in the diagnosis of infectious bursal disease. Trop Anim Health Prod (2000) 0.75
Expression and purification of human interleukin-2 simplified as a fusion with green fluorescent protein in suspended Sf-9 insect cells. J Biotechnol (1999) 0.75
Comparative analysis of virus-induced polypeptides of an avirulent and a virulent strain of avian reovirus. Avian Dis (1994) 0.75